ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

In Brief: Beahrs, Murphy, Quan Honored By SSO; AACR Award Mulligan, Wiggler, Sporn, Witte

March 29, 1991

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

Government Remains open Under Budget Agreement; New Deadlines Are Oct. 5 & 19

October 5, 1990

Funding opportunities listed.

October 8, 2004